✦ LIBER ✦

Concomitant oral tyrosine kinase inhibitors and bisphosphonates in advanced renal cell carcinoma with bone metastases

✍ Scribed by Beuselinck, B; Wolter, P; Karadimou, A; Elaidi, R; Dumez, H; Rogiers, A; Van Cann, T; Willems, L; Body, J-J; Berkers, J; Van Poppel, H; Lerut, E; Debruyne, P; Paridaens, R; Schöffski, P

Book ID: 118004333
Publisher: Nature Publishing Group
Year: 2012
Tongue: English
Weight: 322 KB
Volume: 107
Category: Article
ISSN: 0007-0920
DOI: 10.1038/bjc.2012.385

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prognostic Significance of Bone Metastas

Prognostic Significance of Bone Metastases and Bisphosphonate Therapy in Patients with Renal Cell Carcinoma

✍ McKay, Rana R.; Lin, Xun; Perkins, Julia J.; Heng, Daniel Y.C.; Simantov, Ronit; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 358 KB

Comprehensive overview of the efficacy a

Comprehensive overview of the efficacy and safety of sorafenib in advanced or metastatic renal cell carcinoma after a first tyrosine kinase inhibitor

✍ F. J. Afonso, U. Anido, O. Fernández-Calvo… 📂 Article 📅 2013 🏛 Springer Milan 🌐 Spanish ⚖ 222 KB

794 ORAL Randomized Phase III trial of t

794 ORAL Randomized Phase III trial of the multi-kinase inhibitor sorafenib (BAY 43–9006) in patients with advanced renal cell carcinoma (RCC)

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 141 KB

Are Tyrosine Kinase Inhibitors Still Act

Are Tyrosine Kinase Inhibitors Still Active in Patients With Metastatic Renal Cell Carcinoma Previously Treated With a Tyrosine Kinase Inhibitor and Everolimus? Experience of 36 Patients Treated in France in the RECORD-1 Trial

✍ Blesius, Aurore; Beuselinck, Benoit; Chevreau, Christine; Ravaud, Alain; Rolland 📂 Article 📅 2013 🏛 CIG Media Group, LP. 🌐 English ⚖ 303 KB

MP57-03 SEQUENTIAL USE OF MAMMALIAN TARG

MP57-03 SEQUENTIAL USE OF MAMMALIAN TARGET OF RAPAMYCIN INHIBITORS IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA FOLLOWING FAILURE OF TYROSINE KINASE INHIBITORS

✍ Harada, Ken-ichi; Miyake, Hideaki; Fujisawa, Masato 📂 Article 📅 2014 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 143 KB

Erratum to: Comprehensive overview of th

Erratum to: Comprehensive overview of the efficacy and safety of sorafenib in advanced or metastatic renal cell carcinoma after a first tyrosine kinase inhibitor

✍ F. J. Afonso, U. Anido, O. Fernández-Calvo… 📂 Article 📅 2013 🏛 Springer Milan 🌐 Spanish ⚖ 111 KB